BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38306895)

  • 21. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
    Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
    Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting ACC1 in T cells ameliorates psoriatic skin inflammation.
    Kao YS; Mamareli P; Dhillon-LaBrooy A; Stüve P; Godoy GJ; Velasquez LN; Raker VK; Weidenthaler-Barth B; Boukhallouk F; Rampoldi F; Berod L; Sparwasser T
    J Mol Med (Berl); 2023 Sep; 101(9):1153-1166. PubMed ID: 37594540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin.
    Johnson-Huang LM; Suárez-Fariñas M; Pierson KC; Fuentes-Duculan J; Cueto I; Lentini T; Sullivan-Whalen M; Gilleaudeau P; Krueger JG; Haider AS; Lowes MA
    J Invest Dermatol; 2012 Apr; 132(4):1177-87. PubMed ID: 22277938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis.
    Leijten EF; van Kempen TS; Olde Nordkamp MA; Pouw JN; Kleinrensink NJ; Vincken NL; Mertens J; Balak DMW; Verhagen FH; Hartgring SA; Lubberts E; Tekstra J; Pandit A; Radstake TR; Boes M
    Arthritis Rheumatol; 2021 Jul; 73(7):1220-1232. PubMed ID: 33452865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis via upregulating transforming growth factor-β receptor.
    Jiao J; Zhao X; Wang Y; Liang N; Li J; Yang X; Xing J; Zhou L; Li J; Hou R; Li X; Zhang K
    J Dermatol; 2022 Oct; 49(10):988-997. PubMed ID: 35766154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
    Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
    J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target tissue ectoenzyme CD39/CD73-expressing Foxp3+ regulatory T cells in patients with psoriasis.
    Zhang HY; Yan KX; Huang Q; Ma Y; Fang X; Han L
    Clin Exp Dermatol; 2015 Mar; 40(2):182-91. PubMed ID: 25284153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma.
    Chen B; Zhang D; Zhou J; Li Q; Zhou L; Li SM; Zhu L; Chou KY; Zhou L; Tao L; Lu LM
    Oncol Rep; 2013 Sep; 30(3):1380-90. PubMed ID: 23835793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3
    Pouw JN; Olde Nordkamp MAM; van Kempen T; Concepcion AN; van Laar JM; van Wijk F; Spierings J; Leijten EFA; Boes M
    Sci Rep; 2022 Nov; 12(1):20675. PubMed ID: 36450783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.
    Homey B; Dieu-Nosjean MC; Wiesenborn A; Massacrier C; Pin JJ; Oldham E; Catron D; Buchanan ME; Müller A; deWaal Malefyt R; Deng G; Orozco R; Ruzicka T; Lehmann P; Lebecque S; Caux C; Zlotnik A
    J Immunol; 2000 Jun; 164(12):6621-32. PubMed ID: 10843722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dimeric translationally controlled tumor protein-binding peptide 2 attenuates imiquimod-induced psoriatic inflammation through induction of regulatory T cells.
    Cho H; Je JH; Kang J; Jeong MG; Song J; Jeon Y; Lee K; Hwang ES
    Biomed Pharmacother; 2022 Aug; 152():113245. PubMed ID: 35689858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization.
    Chang HW; Yan D; Singh R; Liu J; Lu X; Ucmak D; Lee K; Afifi L; Fadrosh D; Leech J; Vasquez KS; Lowe MM; Rosenblum MD; Scharschmidt TC; Lynch SV; Liao W
    Microbiome; 2018 Sep; 6(1):154. PubMed ID: 30185226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.
    Sugiyama H; Gyulai R; Toichi E; Garaczi E; Shimada S; Stevens SR; McCormick TS; Cooper KD
    J Immunol; 2005 Jan; 174(1):164-73. PubMed ID: 15611238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional Phenotypic Diversity of Regulatory T Cells Remaining in Inflamed Skin.
    Ikebuchi R; Fujimoto M; Nakanishi Y; Okuyama H; Moriya T; Kusumoto Y; Tomura M
    Front Immunol; 2019; 10():1098. PubMed ID: 31156643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance.
    Chen J; Wang X; Cui T; Ni Q; Zhang Q; Zou D; He K; Wu W; Ma J; Wang Y; Guo W; Li C; Li S
    J Autoimmun; 2022 Jul; 131():102859. PubMed ID: 35792518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing.
    Sobolev VV; Mezentsev AV; Ziganshin RH; Soboleva AG; Denieva M; Korsunskaya IM; Svitich OA
    PLoS One; 2021; 16(5):e0240956. PubMed ID: 34038424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.
    Kotb IS; Lewis BJ; Barker RN; Ormerod AD
    Br J Dermatol; 2018 Jul; 179(1):127-135. PubMed ID: 29330859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.
    Szentpetery A; Heffernan E; Gogarty M; Mellerick L; McCormack J; Haroon M; Elmamoun M; Gallagher P; Kelly G; Fabre A; Kirby B; FitzGerald O
    Arthritis Res Ther; 2017 Jul; 19(1):158. PubMed ID: 28679449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
    Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
    Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis.
    Bosè F; Petti L; Diani M; Moscheni C; Molteni S; Altomare A; Rossi RL; Talarico D; Fontana R; Russo V; Altomare G; Reali E
    Am J Pathol; 2013 Aug; 183(2):413-21. PubMed ID: 23731727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.